pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

481 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT785Endpoints590BioPharma Dive228onclive165BioSpace63Fierce Biotech63raps25
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology
  • Draig bags another $65M to speed testing of brain drugs
    <figure><div><img src="https://imgproxy.divecdn.com/sqRrwC4fH07CJwl4OWuhzdMDEpaPHPepifZhKYJEN9Q/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy02MjU3NTYzODZfWFdob…
    BioPharma Dive · 13d ago↗ source
  • Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs
    <figure><div><img src="https://imgproxy.divecdn.com/Bdi5M4HMTn0nQ7Ww6DWMZBEaPY1McVmIyhbOSlOBYfo/g:nowe:0:194/c:1920:1085/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS8zODY4NjUwMzI1M…
    BioPharma Dive · 13d ago↗ source
  • Experts: Industry to benefit from focused follow-ups, major deficiency letters in MDUFA VI
    <p>Industry experts say the draft commitment letter for the next Medical Device User Fee Amendments (MDUFA VI) program negotiated by the US Food and Drug Administration (FDA) and the medtech indust…
← prev
page 6 of 20
next →
6
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
raps · 13d ago↗ source
  • Freenome colorectal cancer test data improve on earlier results
    <figure><div><img src="https://imgproxy.divecdn.com/t2eSQFnULTRPQ6pHoF74ilRTdrAlEvvFROsITsihAlw/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMDUzMDQ1NTczLmpwZ…
    BioPharma Dive · 13d ago↗ source
  • Q32 bounces back to claim study success for alopecia drug
    <figure><div><img src="https://imgproxy.divecdn.com/_dT9zKJsCoS0jrFraV8Vdkcut5aCVtKPN0y1PuLlKnE/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTUwMzE2NTA1LmpwZ…
    BioPharma Dive · 14d ago↗ source
  • Agenus surges on study pivot; Apnimed lines up an IPO
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 14d ago↗ source
  • Building a workforce engine for biomanufacturing
    Ohio’s $30M training initiative aims to scale talent pipelines and power life sciences growth statewide.
    Fierce Biotech · 14d ago↗ source
  • Biotech startup funding gap widens despite rebound in VC investment
    <figure><div><img src="https://imgproxy.divecdn.com/P3H5TGon7uXjRD49-L7jbsm0pv5Sbvx3i-CT1yYEXeg/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTM5MDkwNTYwX0lGd…
    BioPharma Dive · 14d ago↗ source
  • GSK, Hansoh ADC extends survival in lung cancer study
    <figure><div><img src="https://imgproxy.divecdn.com/mDk-h3NLB8udDPFuDlI7IPou1i9tJKJYucQXUnhK9vA/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTc3MzEzMjc4LmpwZ…
    BioPharma Dive · 17d ago↗ source
  • ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 17d ago↗ source
  • Roche scraps two Ionis-partnered Huntington’s drugs
    <p>The Swiss pharmaceutical giant told patient groups tominersen didn't delay disease progression in one trial, while a study of a second drug was scrapped because of a safety signal in animal…
    BioPharma Dive · 17d ago↗ source
  • GSK ends brain drug alliance with Alector
    <figure><div><img src="https://imgproxy.divecdn.com/mDk-h3NLB8udDPFuDlI7IPou1i9tJKJYucQXUnhK9vA/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTc3MzEzMjc4LmpwZ…
    BioPharma Dive · 18d ago↗ source
  • HHS plan to speed drug research won’t remove ‘self-inflicted’ delays
    <figure><div><img src="https://imgproxy.divecdn.com/CBRbv7ysPGDg2gR4-a3jhbQNYceSmw-Eq03sjZFRhY4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTk2ODIwNDM5LmpwZ…
    BioPharma Dive · 18d ago↗ source
  • AstraZeneca, Ionis drug fails big heart disease study in major setback
    <figure><div><img src="https://imgproxy.divecdn.com/BEaA7RlZhiBVZ8rfvBq1gV4dfZ4BC5WOow-17uS8d2o/g:nowe:0:100/c:8192:4628/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlc…
    BioPharma Dive · 18d ago↗ source
  • AstraZeneca, GSK intensify China ties with Sino Biopharm deals
    <figure><div><img src="https://imgproxy.divecdn.com/3-9P49KCrlRGe6xhfhkhh6gwLyPKxhxZ8qnm4B-ZxSg/g:nowe:0:158/c:2000:1129/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlc…
    BioPharma Dive · 19d ago↗ source
  • Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 19d ago↗ source
  • Oberland pours up to $400M into MeiraGTx eye gene therapies
    <figure><div><img src="https://imgproxy.divecdn.com/nnTWCzHBd9_O2uNBVPF6xmxcO0M-nRFDpca5z-2Xchs/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDMwNzQzODA0LmpwZ…
    BioPharma Dive · 20d ago↗ source
  • Kailera says obesity pill succeeds in late-stage trial in China
    <figure><div><img src="https://imgproxy.divecdn.com/sHvIDEWnHWODDKUtbWbg7nZxoWKQNqB4C54nc9z4iH4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTc4ODI5MzYyLmpwZ…
    BioPharma Dive · 20d ago↗ source
  • Vertex to acquire Crinetics in $10B foray into endocrine disease drugs
    <p>Vertex claimed the two drugs in the deal could eventually bring in more than $5 billion annually. Still, the high price it paid stirred debate among analysts and investors.</p>
    BioPharma Dive · 20d ago↗ source
  • Vera Therapeutics wins FDA nod for closely watched kidney disease drug
    <figure><div><img src="https://imgproxy.divecdn.com/f5a4VRDXQg-SwH2yBDKHbtLeyVHpX8cemnSbe-t-6xU/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjI3NzEwNDk4X0F5Q…
    BioPharma Dive · 20d ago↗ source
  • Gene editing developer Scribe plots an IPO
    <figure><div><img src="https://imgproxy.divecdn.com/sBtYKKH5sscDVuLjDSQCOXakDVLL95AbneXd6jzxisM/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS8yUFA2NlhKLmpwZw==.webp"/></div></f…
    BioPharma Dive · 21d ago↗ source
  • Novartis to acquire ADC developer in a deal worth up to $1.5B
    <p>The deal hands over two ADCs with a different mechanism of action targeting cell growth, and marks Novartis' entry into ADC development.</p>
    BioPharma Dive · 21d ago↗ source
  • Cancer, immune drugmakers dominate VC funding so far in 2026
    <figure><div><img src="https://imgproxy.divecdn.com/nnTWCzHBd9_O2uNBVPF6xmxcO0M-nRFDpca5z-2Xchs/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDMwNzQzODA0LmpwZ…
    BioPharma Dive · 21d ago↗ source
  • Beyond Boston: Unlikely cities stake biotech claims
    <figure><div><img src="https://imgproxy.divecdn.com/lHTPvWvEMjW-n2hvHXgcGrQIAti_O2dHFFQGdwbcrzk/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMjI2NDY4ODE4LmpwZ…
    BioPharma Dive · 21d ago↗ source
  • A PureTech startup banks $180M for a new IPF drug
    <figure><div><img src="https://imgproxy.divecdn.com/KuEcOh78IgcBW2NsJQndhSsRzY-l5rCzAaiUoHZ7Exg/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMDkwODIwMzkwLmpwZ…
    BioPharma Dive · 25d ago↗ source